Charlie’s 2026 Outlook: The Year AI Sentiment Breaks
2025 was dominated by political theatre, but the structural story was unfolding in technology. AI capex driving growth while application-layer delivery lagged. That tension will define 2026.
Charlie’s 2026 Outlook: The Year AI Sentiment Breaks
Charlie’s 2026 Outlook: The Year AI Sentiment Breaks
2025 was dominated by political theatre, but the structural story was unfolding in technology. AI capex driving growth while application-layer delivery lagged. That tension will define 2026.
Reading/Watching List for Xmas
Reading/Watching List for Xmas
Whether you’re lounging poolside or hiding from your relatives, here are the books, podcasts, and long-form videos that shaped my thinking this year.
We Need to Talk About the Kevins
We Need to Talk About the Kevins
If we see a Trump ‘yes man’, short-term US rate cuts might juice American stocks, but they could also send long-term bond yields flying. That ripples straight to our shores.
AI’s New Orbital Silicon Valley
AI’s New Orbital Silicon Valley
Bloomberg breaks the biggest IPO news in years, Charlie and Ray explore what it means for early investors in the latest space race.
Prediction double-down for 2026
Prediction double-down for 2026
In my opinion, Tesla has become a symbol of blind AI optimism for retail investors. Whether that’s their promised full self-driving (FSD) or mass-scale robotics in 2026, investors should be ready for another harsh dose of reality.
The Canary is Coughing
The Canary is Coughing
US employment data has long served as an early warning system for the global economy. When American workers start losing jobs, trouble tends to follow…For markets, for Australia, and eventually for your portfolio.
The Problem with Exponentials
The Problem with Exponentials
The difference between AI that can reliably handle two-hour tasks and AI that can handle multi-week tasks isn’t just more capacity. It’s a fundamentally different economic reality.
A Case for Optimism
A Case for Optimism
James’s makes a case for optimism in a market freaking out over tariffs, shutdowns, and AI bubble fears. He thinks three major developments are quietly pointing in the opposite direction to what you may think.
Markets Get Their Shot in the Arm
Markets Get Their Shot in the Arm
We’ve become dependent on the Fed’s needle. Every wobble gets smoothed over with dovish speeches and rate cut hints. Another shot in the arm to send stocks higher.
